SEC Form 4 · accession 0000899243-18-018173
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bart W Wise
Officer — SVP, Legal Affairs
Period of report
Jun 21, 2018
Accepted (ET)
Jun 26, 2018 · 9:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $13.08 | Jun 21, 2018 | A | 25,000 | A | — | Jun 21, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests in 48 monthly installments over the four-year period starting on the last day of June 2018, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.
Remarks
Exhibit 24 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24 to the Form 3 filed by the reporting person on June 26, 2018)